Canton Strategic (CNTN) vs Yarrow Bioscience (YARW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Yarrow Bioscience (YARW) has outperformed Canton Strategic (CNTN) over the past year, losing 7.6% versus a loss of 34.6%. Yarrow Bioscience is the larger company by market cap ($187.1 million vs $170.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTN | YARW |
|---|---|---|
| Share price | $2.15 | $20.11 |
| Market cap | $170.92M | $187.11M |
| 1-day change | +3.13% | +1.21% |
| YTD return | -31.35% | -31.48% |
| 1-year return | -34.59% | -7.58% |
| 5-year return | — | -98.19% |
| EPS (TTM) | $-0.10 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.89 | $46.95 |
| 52-week low | $1.75 | $16.05 |
| Distance from 52-week high | -68.87% | -57.17% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +183.44% |
| Average volume | 758.86K | 88.98K |
| Shares outstanding | 79.68M | 9.30M |
| Employees | 12 | 7 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- YARW has outperformed CNTN by 27.0 percentage points over the past year.
About Canton Strategic
CNTN stock →Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Yarrow Bioscience
YARW stock →Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
CNTN vs YARW FAQ
Which is bigger, Canton Strategic or Yarrow Bioscience?
Yarrow Bioscience (YARW) is larger, with a market capitalization of $187.11M compared with $170.92M for Canton Strategic (CNTN).
Which stock has performed better over the past year, CNTN or YARW?
YARW returned -7.58% over the past 12 months, compared with -34.59% for CNTN (price return, excluding dividends). Past performance does not predict future results.
Are Canton Strategic and Yarrow Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.